The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Systemic Delivery of MicroRNA-181b Inhibits Nuclear Factor-κB Activation, Vascular Inflammation, and Atherosclerosis in Apolipoprotein E–Deficient Mice
Open accessAbstract
Rationale: Activated nuclear factor (NF)-κB signaling in the vascular endothelium promotes the initiation and progression of atherosclerosis. Targeting endothelial NF-κB may provide a novel strategy to limit chronic inflammation. Objective: To examine the role of microRNA-181b (miR-181b) in endothelial NF-κB signaling and effects on atherosclerosis. Methods and Results: MiR-181b expression was reduced in the aortic intima and plasma in apolipoprotein E–deficient mice fed a high-fat diet. Correspondingly, circulating miR-181b in the plasma was markedly reduced in human subjects with coronary artery disease. Systemic delivery of miR-181b resulted in a 2.3-fold overexpression of miR-181b in the aortic intima of apolipoprotein E–deficient mice and suppressed NF-κB signaling revealed by bioluminescence imaging and reduced target gene expression in the aortic arch in apolipoprotein E–deficient/NF-κB-luciferase transgenic mice. MiR-181b significantly inhibited atherosclerotic lesion formation, proinflammatory gene expression and the influx of lesional macrophages and CD4+ T cells in the vessel wall. Mechanistically, miR-181b inhibited the expression of the target gene importin-α3, an effect that reduced NF-κB nuclear translocation specifically in the vascular endothelium of lesions, whereas surprisingly leukocyte NF-κB signaling was unaffected despite a 7-fold overexpression of miR-181b. Our findings uncover that NF-κB nuclear translocation in leukocytes does not involve importin-α3, but rather importin-α5, which miR-181b does not target, highlighting that inhibition of NF-κB signaling in the endothelium is sufficient to mediate miR-181b’s protective effects. Conclusions: Systemic delivery of miR-181b inhibits the activation of NF-κB and atherosclerosis through cell-specific mechanisms in the vascular endothelium. These findings support the rationale that delivery of miR-181b may provide a novel therapeutic approach to treat chronic inflammatory diseases such as atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
NF-κB, Inflammation, and Metabolic Disease
Baker, R. G., Hayden, M. S., & Ghosh, S. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.008 · Cited by 1,952 · cited 1×
“In the vascular endothelium, NF-κB activation induces the expression of proinflammatory genes, including those encoding adhesion molecules, cytokines, and chemoattractant proteins that collectively play critical roles in the initiation and progression of atherosclerosis.(8,11,12) Consistent with this premise, endothel…”
BackgroundCrosstalk in NF-κB Signaling Pathways
Oeckinghaus, A., Hayden, M. S., & Ghosh, S. (2011) · Nature Immunology · doi:10.1038/ni.2065 · Cited by 1,942
The Framingham Study: The Epidemiology of Atherosclerotic Disease
Dawber, T. R. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674492097 · Cited by 1,454
Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation
Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., & Siebenlist, U. (1995) · Science · doi:10.1126/science.7878466 · Cited by 1,434
Diabetes and cardiovascular disease
Howard, B. V., & Magee, M. F. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0046-8 · Cited by 1,381
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis
Cybulsky, M. I., Iiyama, K., Li, H., Zhu, S., Chen, M., Iiyama, M., Davis, V., Gutierrez-Ramos, J.-C., Connelly, P. W., & Milstone, D. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11871 · Cited by 1,217
(2005) · doi:10.1093/nar/gki200 · Cited by 1,208
miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection
Li, Q.-J., Chau, J., Ebert, P. J. R., Sylvester, G., Min, H., Liu, G., Braich, R., Manoharan, M., Soutschek, J., Skare, P., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.008 · Cited by 1,157
MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1
Harris, T. A., Yamakuchi, M., Ferlito, M., Mendell, J. T., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707493105 · Cited by 1,010
Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity
Chen, Z. J., Parent, L., & Maniatis, T. (1996) · Cell · doi:10.1016/s0092-8674(00)81064-8 · Cited by 951
Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L., & Struhl, K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.07.023 · Cited by 830
Nuclear Factor κB Signaling in Atherogenesis
de Winther, M. P. J., Kanters, E., Kraal, G., & Hofker, M. H. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160340.72641.87 · Cited by 575
Hajra, L., Evans, A. I., Chen, M., Hyduk, S. J., Collins, T., & Cybulsky, M. I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9052 · Cited by 574
Inhibition of Tumor Necrosis Factor-α Reduces Atherosclerosis in Apolipoprotein E Knockout Mice
Brånén, L., Hovgaard, L., Nitulescu, M., Bengtsson, E., Nilsson, J., & Jovinge, S. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000143933.20616.1b · Cited by 495
Hernández-Presa, M., Bustos, C., Ortego, M., Tuñon, J., Renedo, G., Ruiz-Ortega, M., & Egido, J. (1997) · Circulation · doi:10.1161/01.cir.95.6.1532 · Cited by 494
Palinski, W., Ord, V. A., Plump, A. S., Breslow, J. L., Steinberg, D., & Witztum, J. L. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.605 · Cited by 488
The combined role of P- and E-selectins in atherosclerosis.
Dong, Z. M., Chapman, S. M., Brown, A. A., Frenette, P. S., Hynes, R. O., & Wagner, D. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3001 · Cited by 459
MicroRNA-181b regulates NF-κB–mediated vascular inflammation
Sun, X., Icli, B., Wara, A. K., Belkin, N., He, S., Kobzik, L., Hunninghake, G. M., Vera, M. P., Blackwell, T. S., Baron, R. M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61495 · Cited by 444
Self-citationFang, Y., Shi, C., Manduchi, E., Civelek, M., & Davies, P. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002120107 · Cited by 427
Micro RNA ‐146 represses endothelial activation by inhibiting pro‐inflammatory pathways
Cheng, H. S., Sivachandran, N., Lau, A., Boudreau, E., Zhao, J. L., Baltimore, D., Delgado‐Olguin, P., Cybulsky, M. I., & Fish, J. E. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202318 · Cited by 417
Endothelial Cell-Specific NF-κB Inhibition Protects Mice from Atherosclerosis
Gareus, R., Kotsaki, E., Xanthoulea, S., van der Made, I., Gijbels, M. J. J., Kardakaris, R., Polykratis, A., Kollias, G., de Winther, M. P. J., & Pasparakis, M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.016 · Cited by 386
Li, G., Yu, M., Lee, W.-W., Tsang, M., Krishnan, E., Weyand, C. M., & Goronzy, J. J. (2012) · Nature Medicine · doi:10.1038/nm.2963 · Cited by 349
Kanters, E., Pasparakis, M., Gijbels, M. J. J., Vergouwe, M. N., Partouns-Hendriks, I., Fijneman, R. J. A., Clausen, B. E., Förster, I., Kockx, M. M., Rajewsky, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18580 · Cited by 340
Suárez, Y., Wang, C., Manes, T. D., & Pober, J. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902369 · Cited by 320
NF-κB Is Transported into the Nucleus by Importin α3 and Importin α4
Fagerlund, R., Kinnunen, L., Köhler, M., Julkunen, I., & Melén, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500814200 · Cited by 290
Kempe, S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki836 · Cited by 284
Henao-Mejia, J., Williams, A., Goff, L. A., Staron, M., Licona-Limón, P., Kaech, S. M., Nakayama, M., Rinn, J. L., & Flavell, R. A. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.021 · Cited by 263
Ebert, P. J. R., Jiang, S., Xie, J., Li, Q.-J., & Davis, M. M. (2009) · Nature Immunology · doi:10.1038/ni.1797 · Cited by 251
miR-181b negatively regulates activation-induced cytidine deaminase in B cells
de Yébenes, V. G., Belver, L., Pisano, D. G., González, S., Villasante, A., Croce, C., He, L., & Ramiro, A. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080579 · Cited by 242
Köhler, M., Ansieau, S., Prehn, S., Leutz, A., Haller, H., & Hartmann, E. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01265-9 · Cited by 228
Cell-specific effects of miR-221/222 in vessels: Molecular mechanism and therapeutic application
Liu, X., Cheng, Y., Yang, J., Xu, L., & Zhang, C. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.11.008 · Cited by 216
MERHISOUSSI, F., KWAK, B., MAGNE, D., CHADJICHRISTOS, C., BERTI, M., PELLI, G., JAMES, R., MACH, F., & GABAY, C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.008 · Cited by 200
Bourdillon, M.-C., Poston, R. N., Covacho, C., Chignier, E., Bricca, G., & McGregor, J. L. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.12.2630 · Cited by 164
Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
Albers, J., Rajski, M., Schönenberger, D., Harlander, S., Schraml, P., von Teichman, A., Georgiev, S., Wild, P. J., Moch, H., Krek, W., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202231 · Cited by 160
Prox1 expression is negatively regulated by miR-181 in endothelial cells
Kazenwadel, J., Michael, M. Z., & Harvey, N. L. (2010) · Blood · doi:10.1182/blood-2009-12-256297 · Cited by 159
Kanters, E., Gijbels, M. J., van der Made, I., Vergouwe, M. N., Heeringa, P., Kraal, G., Hofker, M. H., & de Winther, M. P. J. (2003) · Blood · doi:10.1182/blood-2003-05-1450 · Cited by 111
p53 and NF-κB Crosstalk: IKKα Tips the Balance
Tergaonkar, V., & Perkins, N. D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.006 · Cited by 97
NF-κB p52, RelB and c-Rel are transported into the nucleus via a subset of importin α molecules
Fagerlund, R., Melén, K., Cao, X., & Julkunen, I. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.03.012 · Cited by 87
Davies, P. F., Polacek, D. C., Handen, J. S., Helmke, B. P., & DePaola, N. (1999) · Trends in biotechnology · doi:10.1016/s0167-7799(99)01348-7 · Cited by 84
MicroRNA‐181b and microRNA‐9 mediate arsenic‐induced angiogenesis via NRP1
Cui, Y., Han, Z., Hu, Y., Song, G., Hao, C., Xia, H.-F., & Ma, X. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22789 · Cited by 80
Park, S., Sui, Y., Gizard, F., Xu, J., Rios-Pilier, J., Helsley, R. N., Han, S., & Zhou, C. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.254573 · Cited by 57
Polykratis, A., Loo, G., Xanthoulea, S., Hellmich, M., & Pasparakis, M. (2012) · Circulation · doi:10.1161/circulationaha.112.100339 · Cited by 53
Ashida, N., SenBanerjee, S., Kodama, S., Foo, S. Y., Coggins, M. P., Spencer, J. A., Zamiri, P., Shen, D., Li, L., Sciuto, T. E., et al. (2011) · Nature Communications · doi:10.1038/ncomms1317 · Cited by 41
Myeloid IκBα Deficiency Promotes Atherogenesis by Enhancing Leukocyte Recruitment to the Plaques
Goossens, P., Vergouwe, M. N., Gijbels, M. J., Curfs, D. M. J., van Woezik, J. H. G., Hoeksema, M. A., Xanthoulea, S., Leenen, P. J. M., Rupec, R. A., Hofker, M. H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022327 · Cited by 37
Cited by
Low Wang, C. C., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,155
MicroRNA Regulation of Atherosclerosis
Feinberg, M. W., & Moore, K. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306300 · Cited by 627
Self-citationTargeting vascular (endothelial) dysfunction
Daiber, A., Steven, S., Weber, A., Shuvaev, V. V., Muzykantov, V. R., Laher, I., Li, H., Lamas, S., & Münzel, T. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13517 · Cited by 501
“An interesting example is posed by miR-181b, which inhibits NF-κB activation, vascular inflammation and atherosclerosis in ApoE-deficient mice that were systemically treated with the miRNA (Sun et al., 2014).”
BackgroundNon-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives
Poller, W., Dimmeler, S., Heymans, S., Zeller, T., Haas, J., Karakas, M., Leistner, D.-M., Jakob, P., Nakagawa, S., Blankenberg, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx165 · Cited by 408
Exosomal MicroRNA Transfer Into Macrophages Mediates Cellular Postconditioning
de Couto, G., Gallet, R., Cambier, L., Jaghatspanyan, E., Makkar, N., Dawkins, J. F., Berman, B. P., & Marbán, E. (2017) · Circulation · doi:10.1161/circulationaha.116.024590 · Cited by 340
Metadata
- Authors
- Sun, X., He, S., Wara, A. K. M., Icli, B., Shvartz, E., Tesmenitsky, Y., Belkin, N., Li, D., Blackwell, T. S., Sukhova, G. K., Croce, K., & Feinberg, M. W.
- Venue
- Circulation Research
- Published
- 2014-01-03
- Volume
- 114
- Issue
- 1
- Pages
- 32-40
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2149269381
- Cited by
- 292
- References
- 49
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.